JPMorgan cuts target to USD 17.00 for Sotera Health stock

Published on 10/15/2026 at 21:47 | Editorial responsibility: Rafael Müller, Editor-in-Chief AD HOC NEWS

The high was EUR 17.20 on September 17, 2026. Sotera Health stock costs EUR 16.20 on October 15, 2026, up 1.89 percent versus Tradegate close.

Analyst target and reporting date

JPMorgan set a USD 17.00 target and downgraded Sotera Health on October 14, 2026.
The 52-week high was EUR 17.20 on September 17, 2026.
Sotera Health stock costs EUR 16.20 at Lang & Schwarz on October 15, 2026 at 9:37 p.m. CEST, up 1.89 percent versus the Tradegate close of October 14, 2026.
The next quarterly report is scheduled for November 3, 2026.

SHC, US83601L1026, Illustration mit AI erstellt.

JPMorgan downgraded Sotera Health from Neutral to Underweight and cut its price target from USD 18.00 to USD 17.00 on October 14, 2026, according to Markets Insider. Against the USD 18.14 Nasdaq price on October 15, 2026 at 3:44 p.m. ET, the new target sits 6.29 percent lower. At Lang & Schwarz, Sotera Health stock was trading at EUR 16.20 on October 15, 2026 at 9:37 p.m. CEST, up 1.89 percent versus the Tradegate close of October 14, 2026.

The 52-week range sets the frame

The Tradegate quote page placed the 52-week range at EUR 11.40 to EUR 17.20 as of October 14, 2026. The Lang & Schwarz price was 5.81 percent below the high and 42.11 percent above the low, putting the stock closer to its yearly peak than its floor.

Trading activity also remained below the average US session pace. Sotera Health volume reached 1,430,326 shares on October 15, 2026, compared with an average of 2,428,035 shares, while the home-market price was up 2.32 percent in US trading.

Revenue growth meets a November date

Sotera Health reported USD 321.38 million of revenue for the second quarter of 2026, up 9.20 percent year over year, in its August 6, 2026 release. The company also reported USD 54.00 million of net income, or USD 0.19 per diluted share, versus USD 8.00 million and USD 0.03 in the second quarter of 2025, according to Sotera Health.

The next quarterly reporting date is November 3, 2026. The company operates through Sterigenics, Nordion and Nelson Labs, providing sterilization, laboratory testing and advisory services for healthcare customers.

Comparison with peers

Sotera Health: up 1.89 percent, P/E 31.69, market capitalization USD 5.2 billion

Thermo Fisher Scientific (NYSE, USD): up 3.92 percent, P/E 37.60, market capitalization USD 258.7 billion

ResMed (NYSE, USD): up 2.87 percent, P/E 23.28, market capitalization USD 34.0 billion

The price after the Xetra session

The euro quote stood 1.89 percent above the Tradegate close of October 14, 2026. In US trading, Sotera Health last traded at USD 18.14 on October 15, 2026 at 3:44 p.m. ET.

The further course of trading is shown by the continuously updated real-time quote of Sotera Health stock.